{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:07:34Z","timestamp":1789913254581,"version":"4.0.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T00:00:00Z","timestamp":1225152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Immune Based Ther Vaccines"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1476-8518-6-6","type":"journal-article","created":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T19:13:46Z","timestamp":1225221226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["CXCL10 blockade protects mice from cyclophosphamide-induced cystitis"],"prefix":"10.1186","volume":"6","author":[{"given":"Senthilkumar K","family":"Sakthivel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udai P","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis D","family":"Taub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian R","family":"Novakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"James W","family":"Lillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,28]]},"reference":[{"key":"46_CR1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-5347(17)43268-X","volume":"138","author":"PM Hanno","year":"1987","unstructured":"Hanno PM, Wein AJ: Interstitial cystitis. J Urol. 1987, 138: 595-6.","journal-title":"J Urol"},{"key":"46_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0094-0143(21)00592-9","volume":"21","author":"PM Hanno","year":"1994","unstructured":"Hanno PM: Diagnosis of interstitial cystitis. Urol Clin North Am. 1994, 21: 63-6.","journal-title":"Urol Clin North Am"},{"key":"46_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0090-4295(01)01112-8","volume":"57","author":"PM Hanno","year":"2001","unstructured":"Hanno PM, Sant GR: Clinical highlights of the National Institute of Diabetes and Digestive and Kidney Diseases\/Interstitial Cystitis Association scientific conference on interstitial cystitis. Urology. 2001, 57: 2-6. 10.1016\/S0090-4295(01)01112-8.","journal-title":"Urology"},{"key":"46_CR4","first-page":"27","volume":"29","author":"R Perez-Marrero","year":"1987","unstructured":"Perez-Marrero R, Emerson L, Juma S: Urodynamic studies in interstitial cystitis. Urology. 1987, 29: 27-30.","journal-title":"Urology"},{"key":"46_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0090-4295(01)01131-1","volume":"57","author":"GR Sant","year":"2001","unstructured":"Sant GR, Hanno PM: Interstitial cystitis: current issues and controversies in diagnosis. Urology. 2001, 57: 82-8. 10.1016\/S0090-4295(01)01131-1.","journal-title":"Urology"},{"key":"46_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.urology.2006.03.084","volume":"69","author":"CL Parsons","year":"2007","unstructured":"Parsons CL: The role of the urinary epithelium in the pathogenesis of interstitial cystitis\/prostatitis\/urethritis. Urology. 2007, 69: 9-16. 10.1016\/j.urology.2006.03.084.","journal-title":"Urology"},{"key":"46_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000281847","volume":"42","author":"H Themann","year":"1987","unstructured":"Themann H, Oberdorf E, Brock N, Pohl J: Electron microscopic investigations of the cyclophosphamide-induced lesions of the urinary bladder of the rat and their prevention by mesna. Urol Int. 1987, 42: 37-43.","journal-title":"Urol Int"},{"key":"46_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1096-9861(20000508)420:3<335::AID-CNE5>3.0.CO;2-#","volume":"420","author":"MA Vizzard","year":"2000","unstructured":"Vizzard MA: Up-regulation of pituitary adenylate cyclase-activating polypeptide in urinary bladder pathways after chronic cystitis. J Comp Neurol. 2000, 420: 335-48. 10.1002\/(SICI)1096-9861(20000508)420:3<335::AID-CNE5>3.0.CO;2-#.","journal-title":"J Comp Neurol"},{"key":"46_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/exnr.1999.7254","volume":"161","author":"MA Vizzard","year":"2000","unstructured":"Vizzard MA: Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol. 2000, 161: 273-84. 10.1006\/exnr.1999.7254.","journal-title":"Exp Neurol"},{"key":"46_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0006-8993(99)01936-8","volume":"844","author":"MA Vizzard","year":"1999","unstructured":"Vizzard MA, Boyle MM: Increased expression of growth-associated protein (GAP-43) in lower urinary tract pathways following cyclophosphamide (CYP)-induced cystitis. Brain Res. 1999, 844: 174-87. 10.1016\/S0006-8993(99)01936-8.","journal-title":"Brain Res"},{"key":"46_CR11","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1523\/JNEUROSCI.19-11-04644.1999","volume":"19","author":"N Yoshimura","year":"1999","unstructured":"Yoshimura N, de Groat WC: Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J Neurosci. 1999, 19: 4644-53.","journal-title":"J Neurosci"},{"key":"46_CR12","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1590\/S0100-879X2006001100011","volume":"39","author":"CK Batista","year":"2006","unstructured":"Batista CK, Brito GA, Souza ML, Leitao BT, Cunha FQ, Ribeiro RA: A model of hemorrhagic cystitis induced with acrolein in mice. Braz J Med Biol Res. 2006, 39: 1475-81.","journal-title":"Braz J Med Biol Res"},{"key":"46_CR13","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/j.1464-410X.2007.06773.x","volume":"99","author":"DE Bjorling","year":"2007","unstructured":"Bjorling DE, Elkahwaji JE, Bushman W, Janda LM, Boldon K, Hopkins WJ, Wang Z-Y: Acute acrolein-induced cystitis in mice. BJU Intl. 2007, 99: 1523-9. 10.1111\/j.1464-410X.2007.06773.x.","journal-title":"BJU Intl"},{"key":"46_CR14","doi-asserted-by":"publisher","first-page":"R677","DOI":"10.1152\/ajpregu.00305.2007","volume":"293","author":"MB Klinger","year":"2007","unstructured":"Klinger MB, Dattilio A, Vizzard MA: Expression of cyclooxygenase-2 in urinary bladder in rats with cyclophosphamide-induced cystitis. Am J Physiol Regul Integr Comp Physiol. 2007, 293: R677-85.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"46_CR15","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/bjp.2008.6","volume":"153","author":"MC Andersson","year":"2008","unstructured":"Andersson MC, Tobin G, Giglio D: Cholinergic nitric oxide release from the urinary bladder mucosa in cyclophosphamide-induced cystitis of the anaesthetized rat. Br J Pharmacol. 2008, 153: 1438-44. 10.1038\/bjp.2008.6.","journal-title":"Br J Pharmacol"},{"key":"46_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.neuint.2003.09.009","volume":"45","author":"J Wieseler-Frank","year":"2004","unstructured":"Wieseler-Frank J, Maier SF, Watkins LR: Glial activation and pathological pain. Neurochem Int. 2004, 45: 389-95. 10.1016\/j.neuint.2003.09.009.","journal-title":"Neurochem Int"},{"key":"46_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nrn1700","volume":"6","author":"F Marchand","year":"2005","unstructured":"Marchand F, Perretti M, McMahon SB: Role of the immune system in chronic pain. Nat Rev Neurosci. 2005, 6: 521-32. 10.1038\/nrn1700.","journal-title":"Nat Rev Neurosci"},{"key":"46_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.autneu.2006.02.030","volume":"126\u2013127","author":"R Yuridullah","year":"2006","unstructured":"Yuridullah R, Corrow KA, Malley SE, Vizzard MA: Expression of fractalkine and fractalkine receptor in urinary bladder after cyclophosphamide (CYP)-induced cystitis. Auton Neurosci. 2006, 126\u2013127: 380-9. 10.1016\/j.autneu.2006.02.030.","journal-title":"Auton Neurosci"},{"key":"46_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1744-8069-3-38","volume":"3","author":"S Bhangoo","year":"2007","unstructured":"Bhangoo S, Ren D, Miller RJ, Henry KJ, Lineswala J, Hamdouchi C, Li B, Monahan PE, Chan DM, Ripsch MS, White FA: Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol Pain. 2007, 3: 38-57. 10.1186\/1744-8069-3-38.","journal-title":"Mol Pain"},{"key":"46_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1365-2567.2007.02792.x","volume":"124","author":"SW Seow","year":"2008","unstructured":"Seow SW, Rahmat JN, Bay BH, Lee YK, Mahendran R: Expression of chemokine\/cytokine genes and immune cell recruitment following the instillation of Mycobacterium bovis, bacillus Calmette-Guerin or Lactobacillus rhamnosus strain GG in the healthy murine bladder. Immunology. 2008, 124: 419-27. 10.1111\/j.1365-2567.2007.02792.x.","journal-title":"Immunology"},{"key":"46_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1523-1755.2005.00381.x","volume":"68","author":"G Otto","year":"2005","unstructured":"Otto G, Burdick M, Strieter R, Godaly G: Chemokine response to febrile urinary tract infection. Kidney Int. 2005, 68: 62-70. 10.1111\/j.1523-1755.2005.00381.x.","journal-title":"Kidney Int"},{"key":"46_CR22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-5347(17)41529-1","volume":"140","author":"JY Gillenwater","year":"1988","unstructured":"Gillenwater JY, Wein AJ: Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, MD, August 28\u201329, 1987. J Urol. 1988, 140: 203-6.","journal-title":"J Urol"},{"key":"46_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1152\/physiolgenomics.00117.2001","volume":"9","author":"SE Malley","year":"2002","unstructured":"Malley SE, Vizzard MA: Changes in urinary bladder cytokine mRNA and protein after cyclophosphamide-induced cystitis. Physiol Genomics. 2002, 9: 5-13.","journal-title":"Physiol Genomics"},{"key":"46_CR24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-5347(17)43863-8","volume":"137","author":"M Fall","year":"1987","unstructured":"Fall M, Johansson SL, Aldenborg F: Chronic interstitial cystitis: a heterogeneous syndrome. J Urol. 1987, 137: 35-8.","journal-title":"J Urol"},{"key":"46_CR25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0022-5347(17)40201-1","volume":"143","author":"SL Johansson","year":"1990","unstructured":"Johansson SL, Fall M: Clinical features and spectrum of light microscopic changes in interstitial cystitis. J Urol. 1990, 143: 1118-24.","journal-title":"J Urol"},{"key":"46_CR26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0094-0143(21)00591-7","volume":"21","author":"SL Johansson","year":"1994","unstructured":"Johansson SL, Fall M: Pathology of interstitial cystitis. Urol Clin North Am. 1994, 21: 55-62.","journal-title":"Urol Clin North Am"},{"key":"46_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0090-4295(01)01166-9","volume":"57","author":"JE Tomaszewski","year":"2001","unstructured":"Tomaszewski JE, Landis JR, Russack V, Williams TM, Wang LP, Hardy C, Brensinger C, Matthews YL, Abele ST, Kusek JW, Nyberg LM, Interstitial Cystitis Database Study Group: Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study. Urology. 2001, 57: 67-81. 10.1016\/S0090-4295(01)01166-9.","journal-title":"Urology"},{"key":"46_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/01.jcp.0000132451.50725.ee","volume":"24","author":"TC Theoharides","year":"2004","unstructured":"Theoharides TC: Panic disorder, interstitial cystitis, and mast cells. J Clin Psychopharmacol. 2004, 24: 361-4. 10.1097\/01.jcp.0000132451.50725.ee.","journal-title":"J Clin Psychopharmacol"},{"key":"46_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.urology.2006.08.1109","volume":"69","author":"GR Sant","year":"2007","unstructured":"Sant GR, Kempuraj D, Marchand JE, Theoharides TC: The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology. 2007, 69: 34-40. 10.1016\/j.urology.2006.08.1109.","journal-title":"Urology"},{"key":"46_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1046\/j.1365-2249.2001.01391.x","volume":"123","author":"K Nishioji","year":"2001","unstructured":"Nishioji K, Okanoue T, Itoh Y, Narumi S, Sakamoto M, Nakamura H, Morita A, Kashima K: Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes. Clin Exp Immunol. 2001, 123: 271-9. 10.1046\/j.1365-2249.2001.01391.x.","journal-title":"Clin Exp Immunol"},{"key":"46_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1006\/cyto.2001.0947","volume":"16","author":"H Kabashima","year":"2001","unstructured":"Kabashima H, Yoneda M, Nagata K, Hirofuji T, Ishihara Y, Yamashita M, Maeda K: The presence of chemokine receptor (CCR5, CXCR3, CCR3)-positive cells and chemokine (MCP1, MIP-1alpha, MIP-1beta, IP-10)-positive cells in human periapical granulomas. Cytokine. 2001, 16: 62-6. 10.1006\/cyto.2001.0947.","journal-title":"Cytokine"},{"key":"46_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/cyto.2002.1985","volume":"20","author":"H Kabashima","year":"2002","unstructured":"Kabashima H, Yoneda M, Nagata K, Hirofuji T, Maeda K: The presence of chemokine (MCP-1, MIP-1alpha, MIP-1beta, IP-10, RANTES)-positive cells and chemokine receptor (CCR5, CXCR3)-positive cells in inflamed human gingival tissues. Cytokine. 2002, 20: 70-7. 10.1006\/cyto.2002.1985.","journal-title":"Cytokine"},{"key":"46_CR33","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.4049\/jimmunol.167.7.4091","volume":"167","author":"MT Liu","year":"2001","unstructured":"Liu MT, Keirstead HS, Lane TE: Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J Immunol. 2001, 167: 4091-7.","journal-title":"J Immunol"},{"key":"46_CR34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/10799900260100114","volume":"22","author":"A Salmaggi","year":"2002","unstructured":"Salmaggi A, Gelati M, Dufour A, Corsini E, Pagano S, Baccalini R, Ferrero E, Scabini S, Silei V, Ciusani E, De Rossi M: Expression and modulation of IFN-gamma-inducible chemokines (IP-10, MIG, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis. J Interferon Cytokine Res. 2002, 22: 631-40. 10.1089\/10799900260100114.","journal-title":"J Interferon Cytokine Res"},{"key":"46_CR35","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.4049\/jimmunol.169.2.1037","volume":"169","author":"JA Belperio","year":"2002","unstructured":"Belperio JA, Keane MP, Burdick MD, Lynch JP, Xue YY, Li K, Ross DJ, Strieter RM: Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol. 2002, 169: 1037-49.","journal-title":"J Immunol"},{"key":"46_CR36","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.161.11.6413","volume":"161","author":"C Agostini","year":"1998","unstructured":"Agostini C, Cassatella M, Zambello R, Trentin L, Gasperini S, Perin A, Piazza F, Siviero M, Facco M, Dziejman M, Chilosi M, Qin S, Luster AD, Semenzato G: Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol. 1998, 161: 6413-20.","journal-title":"J Immunol"},{"key":"46_CR37","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S","volume":"194","author":"J Flier","year":"2001","unstructured":"Flier J, Boorsma DM, van Beek PJ, Nieboer C, Stoof TJ, Willemze R, Tensen CP: Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol. 2001, 194: 398-405. 10.1002\/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S.","journal-title":"J Pathol"},{"key":"46_CR38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0002-9440(10)65128-0","volume":"155","author":"M Uguccioni","year":"1999","unstructured":"Uguccioni M, Gionchetti P, Robbiani DF, Rizzello F, Peruzzo S, Campieri M, Baggiolini M: Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol. 1999, 155: 331-6.","journal-title":"Am J Pathol"},{"key":"46_CR39","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.4049\/jimmunol.171.3.1401","volume":"171","author":"UP Singh","year":"2003","unstructured":"Singh UP, Singh S, Taub DD, Lillard JW: Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10(-\/-) mice. J Immunol. 2003, 171: 1401-06.","journal-title":"J Immunol"},{"key":"46_CR40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1089\/107999003322485099","volume":"23","author":"UP Singh","year":"2003","unstructured":"Singh UP, Singh S, Weaver CT, Iqbal N, McGhee JR, Lillard JW: IFN-\u03b3-inducible chemokines enhance adaptive immunity and colitis. J Interferon Cytokine Res. 2003, 23: 591-600. 10.1089\/107999003322485099.","journal-title":"J Interferon Cytokine Res"},{"key":"46_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2172-9-25","volume":"9","author":"UP Singh","year":"2008","unstructured":"Singh UP, Singh R, Singh S, Karls RK, Quinn FD, Taub DD, Lillard JW: CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis. BMC Immunol. 2008, 9: 25-37. 10.1186\/1471-2172-9-25.","journal-title":"BMC Immunol"},{"key":"46_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/jir.2007.0059","volume":"28","author":"UP Singh","year":"2008","unstructured":"Singh UP, Singh S, Singh R, Cong Y, Taub DD, Lillard JW: CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-\/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition. J Interferon Cytokine Res. 2008, 28: 31-43. 10.1089\/jir.2007.0059.","journal-title":"J Interferon Cytokine Res"},{"key":"46_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/187153007780832109","volume":"7","author":"UP Singh","year":"2007","unstructured":"Singh UP, Venkataraman C, Singh R, Lillard JW: CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication. Endocr Metab Immune Disord Drug Targets. 2007, 7: 111-23. 10.2174\/187153007780832109.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"46_CR44","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1464-410X.1994.tb07635.x","volume":"73","author":"TJ Christmas","year":"1994","unstructured":"Christmas TJ: Lymphocyte sub-populations in the bladder wall in normal bladder, bacterial cystitis and interstitial cystitis. Br J Urol. 1994, 73: 508-15.","journal-title":"Br J Urol"},{"key":"46_CR45","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.4049\/jimmunol.177.10.6603","volume":"177","author":"S Brode","year":"2006","unstructured":"Brode S, Raine T, Zaccone P, Cooke A: Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J Immunol. 2006, 177: 6603-12.","journal-title":"J Immunol"},{"key":"46_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jim.2008.01.012","volume":"333","author":"N Matsushita","year":"2008","unstructured":"Matsushita N, Pilon-Thomas SA, Martin LM, Riker AI: Comparative methodologies of regulatory T cell depletion in a murine melanoma model. J Immunol Methods. 2008, 333: 167-79.","journal-title":"J Immunol Methods"},{"key":"46_CR47","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1615\/CritRevImmunol.v28.i2.20","volume":"28","author":"S Brode","year":"2008","unstructured":"Brode S, Cooke A: Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide. Crit Rev Immunol. 2008, 28: 109-26.","journal-title":"Crit Rev Immunol"},{"key":"46_CR48","first-page":"1002","volume":"8","author":"R-H Schabowsky","year":"2007","unstructured":"Schabowsky R-H, Madireddi S, Sharma R, Yolcu ES, Shirwan H: Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy. Curr Opin Investig Drugs. 2007, 8: 1002-8.","journal-title":"Curr Opin Investig Drugs"},{"key":"46_CR49","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jneuroim.2003.10.036","volume":"146","author":"A Karni","year":"2004","unstructured":"Karni A, Balashov K, Hancock WW, Bharanidharan P, Abraham M, Khoury SJ, Weiner HL: Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis. J Neuroimmunol. 2004, 146: 189-98. 10.1016\/j.jneuroim.2003.10.036.","journal-title":"J Neuroimmunol"},{"key":"46_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1749-6632.2002.tb02949.x","volume":"958","author":"S Sharif","year":"2002","unstructured":"Sharif S, Arreaza GA, Zucker P, Delovitch TL: Regulatory natural killer T cells protect against spontaneous and recurrent type 1 diabetes. Ann NY Acad Sci. 2002, 958: 77-88.","journal-title":"Ann NY Acad Sci"},{"key":"46_CR51","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/nm0901-1057","volume":"7","author":"S Sharif","year":"2001","unstructured":"Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A: Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nature Med. 2001, 7: 1057-62. 10.1038\/nm0901-1057.","journal-title":"Nature Med"},{"key":"46_CR52","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.4049\/jimmunol.162.8.4928","volume":"162","author":"S Gasperini","year":"1999","unstructured":"Gasperini S, Marchi M, Calzetti F, Laudanna C, Vicentini L, Olsen H, Murphy M, Liao F, Farber J, Cassatella MA: Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol. 1999, 162: 4928-37.","journal-title":"J Immunol"},{"key":"46_CR53","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1084\/jem.184.1.241","volume":"184","author":"NJ Davidson","year":"1996","unstructured":"Davidson NJ, Leach MW, Fort MM, Thompson-Snipes L, Kuhn R, Muller W, Berg DJ, Rennick DM: T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med. 1996, 184: 241-51. 10.1084\/jem.184.1.241.","journal-title":"J Exp Med"},{"issue":"5","key":"46_CR54","doi-asserted-by":"crossref","first-page":"G665","DOI":"10.1152\/ajpgi.2000.278.5.G665","volume":"278","author":"TT Pizarro","year":"2000","unstructured":"Pizarro TT, Arseneau KO, Cominelli F: Lessons from genetically engineered animal models XI. Novel mouse models to study pathogenic mechanisms of Crohn's disease. Am J Physiol Gastrointest Liver Physiol. 2000, 278 (5): G665-G669.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"46_CR55","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/gast.2001.20914","volume":"120","author":"MB Dwinell","year":"2001","unstructured":"Dwinell MB, Lugering N, Eckmann L, Kagnoff MF: Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterol. 2001, 120: 49-59. 10.1053\/gast.2001.20914.","journal-title":"Gastroenterol"},{"key":"46_CR56","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1002\/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1","volume":"32","author":"S Sasaki","year":"2002","unstructured":"Sasaki S, Yoneyama H, Suzuki K, Suriki H, Aiba T, Watanabe S, Kawauchi Y, Kawachi H, Shimizu F, Matsushima K, Asakura H, Narumi S: Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival. Eur J Immunol. 2002, 32: 3197-205. 10.1002\/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1.","journal-title":"Eur J Immunol"},{"key":"46_CR57","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1440-1827.2007.02117.x","volume":"57","author":"K Suzuki","year":"2007","unstructured":"Suzuki K, Kawauchi Y, Palaniyandi SS, Veeraveedu PT, Fujii M, Yamagiwa S, Yoneyama H, Han GD, Kawachi H, Okada Y, Ajioka Y, Watanabe K, Hosono M, Asakura H, Aoyagi Y, Narumi S: Blockade of interferon-gamma-inducible protein-10 attenuates chronic experimental colitis by blocking cellular trafficking and protecting intestinal epithelial cells. Pathol Int. 2007, 57: 413-20. 10.1111\/j.1440-1827.2007.02117.x.","journal-title":"Pathol Int"},{"key":"46_CR58","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2340\/00015555-0194","volume":"87","author":"J Wenzel","year":"2007","unstructured":"Wenzel J, Wiechert A, Merkel C, Bieber T, Tuting T: IP10\/CXCL10 \u2013 CXCR3 interaction: a potential self-recruiting mechanism for cytotoxic lymphocytes in lichen sclerosus et atrophicus. Acta Derm Venereol. 2007, 87: 112-7. 10.2340\/00015555-0194.","journal-title":"Acta Derm Venereol"},{"key":"46_CR59","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0002-9440(10)63649-8","volume":"163","author":"W Iijima","year":"2003","unstructured":"Iijima W, Ohtani H, Nakayama T, Sugawara Y, Sato E, Nagura H, Yoshie O, Sasano T: Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES\/CCL5 and IP-10\/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism. Am J Pathol. 2003, 163: 261-8.","journal-title":"Am J Pathol"},{"key":"46_CR60","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s004410000274","volume":"302","author":"NG Frangogiannis","year":"2000","unstructured":"Frangogiannis NG, Mendoza LH, Smith CW, Michael LH, Entman ML: Induction of the synthesis of the C-X-C chemokine interferon-gamma-inducible protein-10 in experimental canine endotoxemia. Cell Tissue Res. 2000, 302: 365-76. 10.1007\/s004410000274.","journal-title":"Cell Tissue Res"},{"key":"46_CR61","first-page":"1103","volume":"28","author":"TN Gomes","year":"1995","unstructured":"Gomes TN, Santos CC, Souza-Filho MV, Cunha FQ, Ribeiro RA: Participation of TNF-alpha and IL-1 in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. Braz J Med Biol Res. 1995, 28: 1103-8.","journal-title":"Braz J Med Biol Res"},{"key":"46_CR62","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0090-4295(99)00162-4","volume":"54","author":"KM Peters","year":"1999","unstructured":"Peters KM, Diokno AC, Steinert BW: Preliminary study on urinary cytokine levels in interstitial cystitis: does intravesical bacille Calmette-Guerin treat interstitial cystitis by altering the immune profile in the bladder?. Urology. 1999, 54: 450-3. 10.1016\/S0090-4295(99)00162-4.","journal-title":"Urology"},{"key":"46_CR63","volume-title":"Urol Res","author":"AB Abdel-Mageed","year":"2003","unstructured":"Abdel-Mageed AB: NF-kappa B-dependent gene expression of proinflammatory cytokines in T24 cells: possible role in interstitial cystitis. Urol Res. 2003"},{"key":"46_CR64","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0022-3565(25)20671-1","volume":"278","author":"LM Renzetti","year":"1996","unstructured":"Renzetti LM, Paciorek PM, Tannu SA, Rinaldi NC, Tocker JE, Wasserman MA, Gater PR: Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways. J Pharmacol Exp Ther. 1996, 278: 847-53.","journal-title":"J Pharmacol Exp Ther"},{"key":"46_CR65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1152\/physiolgenomics.00044.2001","volume":"7","author":"R Saban","year":"2001","unstructured":"Saban R, Saban MR, Nguyen NB, Hammond TG, Wershil BK: Mast cell regulation of inflammation and gene expression during antigen-induced bladder inflammation in mice. Physiol Genomics. 2001, 7: 35-43.","journal-title":"Physiol Genomics"},{"key":"46_CR66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0090-4295(01)01129-3","volume":"57","author":"TC Theoharides","year":"2001","unstructured":"Theoharides TC, Kempuraj D, Sant GR: Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology. 2001, 57: 47-55. 10.1016\/S0090-4295(01)01129-3.","journal-title":"Urology"},{"key":"46_CR67","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0022-5347(05)64750-7","volume":"168","author":"RA Batler","year":"2002","unstructured":"Batler RA, Sengupta S, Forrestal SG, Schaeffer AJ, Klumpp DJ: Mast cell activation triggers a urothelial inflammatory response mediated by tumor necrosis factor-alpha. J Urol. 2002, 168: 819-25. 10.1016\/S0022-5347(05)64750-7.","journal-title":"J Urol"},{"key":"46_CR68","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0167-5699(92)90083-J","volume":"13","author":"S Romagnani","year":"1992","unstructured":"Romagnani S: Induction of TH1 and TH2 responses: a key role for the 'natural' immune response?. Immunol Today. 1992, 13: 379-81. 10.1016\/0167-5699(92)90083-J.","journal-title":"Immunol Today"},{"key":"46_CR69","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0022-5347(17)39611-8","volume":"144","author":"DS Harrington","year":"1990","unstructured":"Harrington DS, Fall M, Johansson SL: Interstitial cystitis: bladder mucosa lymphocyte immunophenotyping and peripheral blood flow cytometry analysis. J Urol. 1990, 144: 868-71.","journal-title":"J Urol"},{"key":"46_CR70","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1084\/jem.187.1.129","volume":"187","author":"R Bonecchi","year":"1998","unstructured":"Bonecchi R, Bianchi G, Bordignon PP, D'ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998, 187: 129-134. 10.1084\/jem.187.1.129.","journal-title":"J Exp Med"},{"key":"46_CR71","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1084\/jem.166.4.1084","volume":"166","author":"AD Luster","year":"1987","unstructured":"Luster AD, Ravetch JV: Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med. 1987, 166: 1084-97. 10.1084\/jem.166.4.1084.","journal-title":"J Exp Med"},{"key":"46_CR72","doi-asserted-by":"publisher","first-page":"A99","DOI":"10.1016\/S0016-5085(08)60466-7","volume":"134","author":"R Hardi","year":"2008","unstructured":"Hardi R, Mayer L, Targan SR, Yellin M, Cardarelli PM, Das KM: A phase 1 open-label, single-dose, dose-escalation study of mdx-1100 a high-affinity, neutralizing, fully human IggIk Anti-CXCL10 (IP10). Gastroenterol. 2008, 134: A99-A100.","journal-title":"Gastroenterol"},{"key":"46_CR73","first-page":"A493","volume":"134","author":"M Yellin","year":"1100","unstructured":"Yellin M, Goldwater R, Blanset DL, Cardarelli PM: A double-blind, placebo-controlled, dose-escalation, safety and pharmacokinetic study of MDX- a fully human anti-CXCL10 monoclonal antibody, in healthy subjects. Gastroenterol. 1100, 134: A493-A494.","journal-title":"Gastroenterol"}],"container-title":["Journal of Immune Based Therapies and Vaccines"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-8518-6-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1476-8518-6-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-8518-6-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T08:12:13Z","timestamp":1738483933000},"score":1,"resource":{"primary":{"URL":"https:\/\/jibtherapies.biomedcentral.com\/articles\/10.1186\/1476-8518-6-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,28]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1186\/1476-8518-6-6","relation":{},"ISSN":["1476-8518"],"issn-type":[{"value":"1476-8518","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,28]]},"assertion":[{"value":"9 July 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"6"}}